potent < potential < potentially

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000012 (2015)	Benzi Kluger [États-Unis] ; Piera Triolo ; Wallace Jones ; Joseph Jankovic [États-Unis]	The therapeutic potential of cannabinoids for movement disorders.
000042 (2015)	Roger L. Albin [États-Unis] ; James F. Burke [États-Unis]	Potential trade-offs in treatment of premanifest Huntington's disease.
000293 (2013)	Lizabeth L. Jordan [États-Unis] ; Laura B. Zahodne [États-Unis] ; Michael S. Okun [États-Unis] ; Dawn Bowers [États-Unis]	Hedonic and Behavioral Deficits Associated with Apathy in Parkinson’s Disease: Potential Treatment Implications
000435 (2012)	Maryka Quik [États-Unis] ; Xiomara A. Perez [États-Unis] ; Tanuja Bordia [États-Unis]	Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease
000673 (2011)	Daniel Weiss [Allemagne] ; Rathinaswamy B. Govindan [États-Unis] ; Albrecht Rilk [Allemagne] ; Tobias W Chter [Allemagne] ; Sorin Breit [Allemagne] ; Leopold Zizlsperger [Allemagne] ; Thomas Haarmeier [Allemagne] ; Christian Plewnia [Allemagne] ; Rejko Krüger [Allemagne] ; Alireza Gharabaghi [Allemagne]	Central oscillators in a patient with neuropathic tremor: Evidence from intraoperative local field potential recordings
000679 (2011)	Daniel Weintraub [États-Unis] ; John C. Morgan [États-Unis]	Both the body and brain benefit from exercise: Potential win‐win for Parkinson's disease patients
000723 (2010)	Gonzalo J. Revuelta [États-Unis] ; Claudia Testa [États-Unis] ; James G. Greene [États-Unis]	Writer's cramp: A potential early feature of Huntington's disease
000743 (2010)	Sara Marceglia [Italie] ; Domenico Servello [Italie] ; Guglielmo Foffani [États-Unis, Espagne] ; Mauro Porta [Italie] ; Marco Sassi [Italie] ; Simona Mrakic-Sposta [Italie] ; Manuela Rosa [Italie] ; Sergio Barbieri [Italie] ; Alberto Priori [Italie]	Thalamic single‐unit and local field potential activity in Tourette syndrome
000758 (2010)	Stuart H. Isaacson [États-Unis]	Selective MAO‐B inhibitors have low potential for the tyramine effect
000847 (2010)	Ruksana Azhu Valappil [États-Unis] ; Jed E. Black [États-Unis] ; Meredith J. Broderick [États-Unis] ; Oscar Carrillo [États-Unis] ; Eric Frenette [Canada] ; Shannon S. Sullivan [États-Unis] ; Samuel M. Goldman [États-Unis] ; Caroline M. Tanner [États-Unis] ; James W. Langston [États-Unis]	Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease
000924 (2010)	RUKSANA AZHU VALAPPIL [États-Unis] ; Jed E. Black [États-Unis] ; Meredith J. Broderick [États-Unis] ; Oscar Carrillo [États-Unis] ; Eric Frenette [Canada] ; Shannon S. Sullivan [États-Unis] ; Samuel M. Goldman [États-Unis] ; Caroline M. Tanner [États-Unis] ; James W. Langston [États-Unis]	Exploring the Electrocardiogram as a Potential Tool to Screen for Premotor Parkinson's Disease
000985 (2009)	Norbert Schuff [États-Unis]	Potential role of high‐field MRI for studies in Parkinson's disease
000D10 (2007)	Susanne May [États-Unis] ; Sid Gilman [États-Unis] ; B. Brooke Sowell [États-Unis] ; Ronald G. Thomas [États-Unis] ; Matthew B. Stern [États-Unis] ; Amy Colcher [États-Unis] ; Caroline M. Tanner [États-Unis] ; Neng Huang [États-Unis] ; Peter Novak [États-Unis] ; Stephen G. Reich [États-Unis] ; Joseph Jankovic [États-Unis] ; William G. Ondo [États-Unis] ; Phillip A. Low [États-Unis] ; Paola Sandroni [États-Unis] ; Axel Lipp [États-Unis] ; Frederick J. Marshall [États-Unis] ; Frederick Wooten [États-Unis] ; Clifford W. Shults [États-Unis]	Potential outcome measures and trial design issues for multiple system atrophy
001080 (2005)	David R. Lynch [États-Unis] ; Jennifer M. Farmer [États-Unis] ; Robert L. Wilson [États-Unis] ; Laura J. Balcer [États-Unis]	Performance measures in Friedreich ataxia: Potential utility as clinical outcome tools
001123 (2005)	Fredricka C. Martin [États-Unis] ; Anh Thu Le [États-Unis] ; Adrian Handforth [États-Unis]	Harmaline‐induced tremor as a potential preclinical screening method for essential tremor medications
001305 (2004)	Fredricka C. Martin [États-Unis] ; ANH THU LE [États-Unis] ; Adrian Handforth [États-Unis]	Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications
001545 (2001)	Elan D. Louis [États-Unis] ; Livia F. Barnes [États-Unis] ; Blair Ford [États-Unis] ; Ruth Ottman [États-Unis]	Family history information on essential tremor: Potential biases related to the source of the cases
001773 (1998)	U J Kang [États-Unis]	Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.
001860 (1998)	UN JUNG KANG [États-Unis]	Potential of gene therapy for Parkinson's disease : Neurobiologic issues and new developments in gene transfer methodologies
001934 (1997)	Caviness [États-Unis] ; Mathias Kurth [États-Unis]	Cortical myoclonus in huntington's disease associated with an enlarged somatosensory evoked potential
001975 (1997)	J. N. Caviness [États-Unis] ; M. Kurth [États-Unis]	Cortical myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/USA/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Title.i -k "potential" 

HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Title.i  \
                -Sk "potential" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    potential
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024